Technology Platform

Pipeline

News Center

Strong Team - Four Senior Experts Join Gmax Biopharm

They will provide Gmax with scientific and strategic advisory on R&D, global multi-center clinical trials, international business development and IPO, etc.

Gmax initiates the multi-region, multi-center clinical trial of Getagozumab in PAH patients

Gmax initiated the multi-region, multi-center clinical trial of Getagozumab in pulmonary arterial hypertension (PAH) patients.